Tropisetron improves deficits in auditory P50 suppression in schizophrenia.

Department of Psychiatry, Chiba University Graduate School of Medicine, Japan.
Schizophrenia Research (Impact Factor: 4.43). 08/2005; 76(1):67-72. DOI: 10.1016/j.schres.2004.12.016
Source: PubMed

ABSTRACT Physiological deficits in inhibition of the P50 auditory evoked potential in schizophrenia have been related to diminished expression of alpha7 nicotinic acetylcholine receptors. Diminished P50 inhibition is correlated with neuropsychological deficits in attention, one of the principal neurocognitive disturbances in schizophrenia. Nicotine administration improves P50 inhibition, presumably by achieving additional activation of these diminished receptors, but its toxicity and marked tachyphylaxis make it an ineffective therapeutic. Nicotine also has weak positive effects on several neurocognitive deficits in schizophrenia, which raises the possibility that the alpha7 nicotinic receptor is a clinically relevant therapeutic target that should be addressed by less toxic agents. Tropisetron, a drug already approved for clinical use outside the United States as an anti-emetic, is a partial agonist at alpha7 nicotinic receptors and an antagonist at 5-HT(3) receptors. As an initial proof-of-principle study, we determined that a single administration of tropisetron significantly improves P50 inhibition in schizophrenia. These data are consistent with biological activity at a pathophysiological mechanism in schizophrenia and support further trials of this drug as a possible therapeutic for neurocognitive deficits in schizophrenia.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Gamma-frequency oscillatory activity plays an important role in information integration across brain areas. Disruption in gamma oscillations is implicated in cognitive impairments in psychiatric disorders, and 5-HT3 receptors (5-HT3Rs) are suggested as therapeutic targets for cognitive dysfunction in psychiatric disorders. Using a 5-HT3aR-EGFP transgenic mouse line and inducing gamma oscillations by carbachol in hippocampal slices, we show that activation of 5-HT3aRs, which are exclusively expressed in cholecystokinin (CCK)-containing interneurons, selectively suppressed and desynchronized firings in these interneurons by enhancing spike-frequency accommodation in a small conductance potassium (SK)-channel-dependent manner. Parvalbumin-positive interneurons therefore received diminished inhibitory input leading to increased but desynchronized firings of PV cells. As a consequence, the firing of pyramidal neurons was desynchronized and gamma oscillations were impaired. These effects were independent of 5-HT3aR-mediated CCK release. Our results therefore revealed an important role of 5-HT3aRs in gamma oscillations and identified a novel crosstalk among different types of interneurons for regulation of network oscillations. The functional link between 5-HT3aR and gamma oscillations may have implications for understanding the cognitive impairments in psychiatric disorders.
    Cerebral Cortex 09/2014; · 8.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sensory gating disturbances in schizophrenia are often described as an inability to filter redundant sensory stimuli that typically manifest as inability to gate neuronal responses related to the P50 wave, characterizing a decreased ability of the brain to inhibit various responses to insignificant stimuli. It implicates various deficits of perceptual and attentional functions, and this inability to inhibit, or "gate", irrelevant sensory inputs leads to sensory and information overload that also may result in neuronal hyperexcitability related to disturbances of habituation mechanisms. These findings seem to be particularly important in the context of modern electrophysiological and neuroimaging data suggesting that the filtering deficits in schizophrenia are likely related to deficits in the integrity of connections between various brain areas. As a consequence, this brain disintegration produces disconnection of information, disrupted binding, and disintegration of consciousness that in terms of modern neuroscience could connect original Bleuler's concept of "split mind" with research of neural information integration.
    Neuropsychiatric Disease and Treatment 01/2014; 10:1309-15. · 2.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Kognitive Dysfunktionen stellen neben der Positiv- und Negativsymptomatik einen zentralen Symptomkomplex der Schizophrenie dar. Obwohl diese Defizite in den Bereichen Aufmerksamkeit, Gedächtnis und Exekutivfunktionen schon lange beschrieben worden sind, rückten sie erst in letzter Zeit in den Fokus der therapeutischen Bemühungen. Die Erkenntnis, dass kognitive Defizite bislang den besten bekannten Prädiktor für die Alltagsfunktionalität schizophrener Patienten bilden, erklärt das zunehmende Interesse an einer Erfassung und Therapie dieser Beeinträchtigungen.Allgemeine Standards, wie durch die MATRICS-Initiative (Measurement and Treatment Research to Improve Cognition in Schizophrenia) vorgestellt, bilden die Grundlage einer verlässlichen Erfassung der Neurokognition bei schizophrenen Patienten.Die im deutschen Sprachraum verbreitetsten kognitiven Trainingsverfahren bei schizophrenen Patienten stellen ,,CogPack“ und das ,,Integrierte Psychologische Therapieprogramm (IPT)“ dar. Vor allem im angloamerikanischen Sprachraum werden weitere kognitive Trainingsprogramme mit unterschiedlicher Schwerpunktsetzung eingesetzt. Insgesamt sind diesbezügliche Studienergebnisse als ermutigend zu bewerten. Eine Verbesserung der kognitiven Einschränkungen bei schizophrenen Patienten ist durch gezieltes Training möglich und kann auch eine Verbesserung des psychosozialen Funktionsniveaus mit sich bringen. Es sind jedoch weitere Studien nötig, um kognitives Training für Menschen mit Schizophrenien zu optimieren.
    Der Nervenarzt 05/2010; 81(5). · 0.86 Impact Factor